BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 1903091)

  • 61. Purification and characterization of cytochrome P-450 with high affinity for 7-alkoxycoumarins.
    Komori M; Imai Y; Sato R
    J Biochem; 1984 May; 95(5):1379-88. PubMed ID: 6430886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Kupffer cell stimulation with Corynebacterium parvum reduces some cytochrome P450-dependent activities and diminishes acetaminophen and carbon tetrachloride-induced liver injury in the rat.
    Raiford DS; Thigpen MC
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):36-45. PubMed ID: 7974494
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli.
    Shimada T; Tsumura F; Gillam EM; Guengerich FP; Inoue K
    Protein Expr Purif; 2000 Oct; 20(1):73-80. PubMed ID: 11035953
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity.
    Imaoka S; Imai Y; Shimada T; Funae Y
    Biochemistry; 1992 Jul; 31(26):6063-9. PubMed ID: 1627548
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN.
    Levine WG; Raza H
    Drug Metab Dispos; 1988; 16(3):441-8. PubMed ID: 2900738
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans-4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation.
    Bestervelt LL; Vaz AD; Coon MJ
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3764-8. PubMed ID: 7731980
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.
    Watanabe K; Matsunaga T; Yamamoto I; Yashimura H
    Drug Metab Dispos; 1995 Feb; 23(2):261-5. PubMed ID: 7736922
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Binding of reactive metabolites of CCl4 to specific microsomal proteins.
    Vittozzi L; Nastainczyk W
    Biochem Pharmacol; 1987 May; 36(9):1401-6. PubMed ID: 3579981
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Purified fusion enzyme between rat cytochrome P4501A1 and yeast NADPH-cytochrome P450 oxidoreductase.
    Hara M; Miyake J; Asada Y; Ohkawa H
    Biosci Biotechnol Biochem; 1999 Jan; 63(1):21-8. PubMed ID: 10052117
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lowering effect of carbon tetrachloride on microsomal cytochrome P-450 of rat liver.
    Ota M; Sato N; Uemura H; Obara K
    Chem Biol Interact; 1975 Oct; 11(4):265-76. PubMed ID: 809145
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
    Kousba A; Soll R; Yee S; Martin M
    Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human recombinant cytochrome P450 enzymes display distinct hydrogen peroxide generating activities during substrate independent NADPH oxidase reactions.
    Mishin V; Heck DE; Laskin DL; Laskin JD
    Toxicol Sci; 2014 Oct; 141(2):344-52. PubMed ID: 25061110
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of cytochrome P450 lysine residues in the interaction between cytochrome P450IA1 and NADPH-cytochrome P450 reductase.
    Shen S; Strobel HW
    Arch Biochem Biophys; 1992 Apr; 294(1):83-90. PubMed ID: 1550361
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential effect of interleukin-1 alpha on rat hepatic cytochrome P450 monooxygenases.
    Sindhu RK; Sakai H; Okamoto T; Kikkawa Y
    Toxicology; 1996 Nov; 114(1):37-46. PubMed ID: 8931759
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in rats.
    Brady JF; Xiao F; Wang MH; Li Y; Ning SM; Gapac JM; Yang CS
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):366-73. PubMed ID: 1850173
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dichloromethane and carbon monoxide inhalation: carboxyhemoglobin addition, and drug metabolizing enzymes in rat.
    Kurppa K; Kivistö H; Vainio H
    Int Arch Occup Environ Health; 1981; 49(1):83-7. PubMed ID: 6795133
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A microsomal membrane component associated with iron reduction in NADPH-supported lipid peroxidation.
    Tampo Y; Yonaha M
    Lipids; 1995 Jan; 30(1):55-62. PubMed ID: 7760689
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of cAMP-dependent protein kinase and ATP on N1-oxidation of 9-benzyladenine by animal hepatic microsomes.
    Liu DY; Gorrod JW
    Life Sci; 2000; 66(1):77-88. PubMed ID: 10658926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Purification and characterization of cytochrome P450 reductase from liver microsomes of feral leaping mullet (Liza saliens).
    Sen A; Arinc E
    J Biochem Mol Toxicol; 1998; 12(2):103-13. PubMed ID: 9443067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.